Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Merck
Boehringer Ingelheim
Fish and Richardson
Medtronic
Colorcon
Julphar
Healthtrust
Cantor Fitzgerald

Generated: February 22, 2018

DrugPatentWatch Database Preview

PERSANTINE Drug Profile

« Back to Dashboard

Which patents cover Persantine, and what generic alternatives are available?

Persantine is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Drug patent expirations by year for PERSANTINE
Pharmacology for PERSANTINE
Medical Subject Heading (MeSH) Categories for PERSANTINE

US Patents and Regulatory Information for PERSANTINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim PERSANTINE dipyridamole TABLET;ORAL 012836-003 Dec 22, 1986 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim PERSANTINE dipyridamole TABLET;ORAL 012836-004 Feb 6, 1987 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim PERSANTINE dipyridamole TABLET;ORAL 012836-005 Feb 6, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
QuintilesIMS
Queensland Health
Fish and Richardson
US Department of Justice
Healthtrust
Federal Trade Commission
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot